{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:45:04Z","timestamp":1792683904253,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"8059","license":[{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2025,4,17]]},"DOI":"10.1038\/s41586-025-08657-0","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T11:03:52Z","timestamp":1738235032000},"page":"793-801","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["HIV immune evasin Nef enhances allogeneic CAR T cell potency"],"prefix":"10.1038","volume":"640","author":[{"given":"Karlo","family":"Perica","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6202-9528","authenticated-orcid":false,"given":"Ivan S.","family":"Kotchetkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Mansilla-Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2245-9352","authenticated-orcid":false,"given":"Fiona","family":"Ehrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhe","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9751-0677","authenticated-orcid":false,"given":"Anton","family":"Dobrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8683-8477","authenticated-orcid":false,"given":"Mithat","family":"G\u00f6nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9031-8025","authenticated-orcid":false,"given":"Michel","family":"Sadelain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,30]]},"reference":[{"key":"8657_CR1","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1056\/NEJMra1706169","volume":"379","author":"CH June","year":"2018","unstructured":"June, C. H. & Sadelain, M. Chimeric antigen receptor therapy. N. Engl. J. Med. 379, 64\u201373 (2018).","journal-title":"N. Engl. J. Med."},{"key":"8657_CR2","doi-asserted-by":"publisher","first-page":"582","DOI":"10.3389\/fimmu.2016.00582","volume":"7","author":"J Marino","year":"2016","unstructured":"Marino, J., Paster, J. & Benichou, G. Allorecognition by T lymphocytes and allograft rejection. Front. Immunol. 7, 582 (2016).","journal-title":"Front. Immunol."},{"key":"8657_CR3","doi-asserted-by":"crossref","unstructured":"Martin, K. E., Hammer, Q., Perica, K., Sadelain, M. & Malmberg, K. J. Engineering immune-evasive allogeneic cellular immunotherapies. Nat. Rev. Immunol. 24, 680\u2013693 (2024).","DOI":"10.1038\/s41577-024-01022-8"},{"key":"8657_CR4","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/nri2575","volume":"9","author":"TH Hansen","year":"2009","unstructured":"Hansen, T. H. & Bouvier, M. MHC class I antigen presentation: learning from viral evasion strategies. Nat. Rev. Immunol. 9, 503\u2013513 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"8657_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bbmt.2017.10.004","volume":"24","author":"AJ Barrett","year":"2018","unstructured":"Barrett, A. J., Prockop, S. & Bollard, C. M. Virus-specific T cells: broadening applicability. Biol. Blood Marrow Transplant. 24, 13\u201318 (2018).","journal-title":"Biol. Blood Marrow Transplant."},{"key":"8657_CR6","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.1158\/0008-5472.CAN-14-3321","volume":"75","author":"LPB Philip","year":"2015","unstructured":"Philip, L. P. B. et al. Multiplex genome-edited T-cell manufacturing platform for \u2018off-the-shelf\u2019 adoptive T-cell immunotherapies. Cancer Res. 75, 3853\u20133864 (2015).","journal-title":"Cancer Res."},{"key":"8657_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature21405","volume":"543","author":"J Eyquem","year":"2017","unstructured":"Eyquem, J. et al. Targeting a CAR to the TRAC locus with CRISPR\/Cas9 enhances tumour rejection. Nature 543, 113\u2013117 (2017).","journal-title":"Nature"},{"key":"8657_CR8","doi-asserted-by":"crossref","unstructured":"Depil, S., Duchateau, P., Grupp, S. A., Mufti, G. & Poirot, L. \u2018Off-the-shelf\u2019 allogeneic CAR T cells: development and challenges. Nat. Rev. Drug Discov. 19, 185\u2013199 (2020).","DOI":"10.1038\/s41573-019-0051-2"},{"key":"8657_CR9","doi-asserted-by":"publisher","first-page":"e833","DOI":"10.1016\/S2352-3026(22)00245-9","volume":"9","author":"R Benjamin","year":"2022","unstructured":"Benjamin, R. et al. UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial. Lancet Haematol. 9, e833\u2013e843 (2022).","journal-title":"Lancet Haematol."},{"key":"8657_CR10","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1146\/annurev-immunol-082619-124440","volume":"38","author":"M Mancini","year":"2020","unstructured":"Mancini, M. & Vidal, S. M. Mechanisms of natural killer cell evasion through viral adaptation. Annu. Rev. Immunol. 38, 511\u2013539 (2020).","journal-title":"Annu. Rev. Immunol."},{"key":"8657_CR11","doi-asserted-by":"crossref","unstructured":"Buffalo, C. Z., Iwamoto, Y., Hurley, J. H. & Ren, X. How HIV Nef proteins hijack membrane traffic to promote infection. J. Virol. 93, e01322-19 (2019).","DOI":"10.1128\/JVI.01322-19"},{"key":"8657_CR12","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1126\/science.1185350","volume":"328","author":"SG Hansen","year":"2010","unstructured":"Hansen, S. G. et al. Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus. Science 328, 102\u2013106 (2010).","journal-title":"Science"},{"key":"8657_CR13","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1093\/embo-reports\/kve141","volume":"2","author":"M Geyer","year":"2001","unstructured":"Geyer, M., Fackler, O. T. & Peterlin, B. M. Structure-function relationships in HIV-1 Nef. EMBO Rep. 2, 580\u2013585 (2001).","journal-title":"EMBO Rep."},{"key":"8657_CR14","doi-asserted-by":"crossref","unstructured":"Deuse, T. et al. Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients. Nat. Biotechnol. 37, 252\u2013258 (2019).","DOI":"10.1038\/s41587-019-0016-3"},{"key":"8657_CR15","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nbt.3860","volume":"35","author":"GG Gornalusse","year":"2017","unstructured":"Gornalusse, G. G. et al. HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells. Nat. Biotechnol. 35, 765\u2013772 (2017).","journal-title":"Nat. Biotechnol."},{"key":"8657_CR16","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nri1087","volume":"3","author":"ML Gougeon","year":"2003","unstructured":"Gougeon, M. L. Apoptosis as an HIV strategy to escape immune attack. Nat. Rev. Immunol. 3, 392\u2013404 (2003).","journal-title":"Nat. Rev. Immunol."},{"key":"8657_CR17","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1089\/aid.2019.0213","volume":"36","author":"AC Paim","year":"2020","unstructured":"Paim, A. C., Badley, A. D. & Cummins, N. W. Mechanisms of human immunodeficiency virus-associated lymphocyte regulated cell death. AIDS Res. Hum. Retroviruses 36, 101\u2013115 (2020).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"8657_CR18","doi-asserted-by":"publisher","first-page":"5426","DOI":"10.1158\/1078-0432.CCR-07-0674","volume":"13","author":"RJ Brentjens","year":"2007","unstructured":"Brentjens, R. J. et al. Genetically targeted T cells eradicate systemic acute lymphoblastic leukemia xenografts. Clin. Cancer Res. 13, 5426\u20135435 (2007).","journal-title":"Clin. Cancer Res."},{"key":"8657_CR19","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3324\/haematol.2019.233882","volume":"106","author":"V Wiebking","year":"2021","unstructured":"Wiebking, V. et al. Genome editing of donor-derived T cells to generate allogeneic chimeric antigen receptor-modified T cells: optimizing a\u03b2 T-cell-depleted haploidentical hematopoietic stem cell transplantation. Haematologica 106, 847\u2013858 (2021).","journal-title":"Haematologica"},{"key":"8657_CR20","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/bjh.17544","volume":"195","author":"K Sanber","year":"2021","unstructured":"Sanber, K., Savani, B. & Jain, T. Graft-versus-host disease risk after chimeric antigen receptor T-cell therapy: the diametric opposition of T cells. Br. J. Haematol. 195, 660\u2013668 (2021).","journal-title":"Br. J. Haematol."},{"key":"8657_CR21","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S1074-7613(00)80065-5","volume":"10","author":"GB Cohen","year":"1999","unstructured":"Cohen, G. B. et al. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10, 661\u2013671 (1999).","journal-title":"Immunity"},{"key":"8657_CR22","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1089\/hum.2005.16.1241","volume":"1246","author":"J Ellis","year":"2005","unstructured":"Ellis, J. Silencing and variegation of gammaretrovirus and lentivirus vectors. Hum. Gene Ther. 1246, 1241\u20131246 (2005).","journal-title":"Hum. Gene Ther."},{"key":"8657_CR23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41591-018-0290-5","volume":"25","author":"J Feucht","year":"2019","unstructured":"Feucht, J. et al. Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency. Nat. Med. 25, 82\u201388 (2019).","journal-title":"Nat. Med."},{"key":"8657_CR24","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1158\/1078-0432.CCR-16-1300","volume":"23","author":"J Ren","year":"2017","unstructured":"Ren, J. et al. Multiplex genome editing to generate universal CAR T cells resistant to PD1 inhibition. Clin. Cancer Res. 23, 2255\u20132266 (2017).","journal-title":"Clin. Cancer Res."},{"key":"8657_CR25","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1146\/annurev-cancerbio-050520-100526","volume":"5","author":"S Guil-Luna","year":"2020","unstructured":"Guil-Luna, S., Sedlik, C. & Piaggio, E. Humanized mouse models to evaluate cancer immunotherapeutics. Annu. Rev. Cancer Biol. 5, 119\u2013136 (2020).","journal-title":"Annu. Rev. Cancer Biol."},{"key":"8657_CR26","doi-asserted-by":"crossref","unstructured":"Creelan, B. C. & Antonia, S. J. The NKG2A immune checkpoint\u2014a new direction in cancer immunotherapy. Nat. Rev. Clin. Oncol. 16, 277\u2013278 (2019).","DOI":"10.1038\/s41571-019-0182-8"},{"key":"8657_CR27","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1182\/blood-2012-10-459545","volume":"121","author":"V B\u00e9ziat","year":"2013","unstructured":"B\u00e9ziat, V. et al. NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood 121, 2678\u20132688 (2013).","journal-title":"Blood"},{"key":"8657_CR28","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2217\/fvl.13.20","volume":"8","author":"TJ Markle","year":"2013","unstructured":"Markle, T. J., Mwimanzi, P. & Brockman, M. A. HIV-1 Nef and T-cell activation: a history of contradictions. Future Virol. 8, 391\u2013404 (2013).","journal-title":"Future Virol."},{"key":"8657_CR29","doi-asserted-by":"publisher","first-page":"6701","DOI":"10.1128\/jvi.70.10.6701-6708.1996","volume":"70","author":"A Greenway","year":"1996","unstructured":"Greenway, A., Azad, A., Mills, J. & McPhee, D. Human immunodeficiency virus type 1 Nef binds directly to Lck and mitogen-activated protein kinase, inhibiting kinase activity. J. Virol. 70, 6701\u20136708 (1996).","journal-title":"J. Virol."},{"key":"8657_CR30","doi-asserted-by":"publisher","first-page":"e1212","DOI":"10.1371\/journal.pone.0001212","volume":"2","author":"C Haller","year":"2007","unstructured":"Haller, C., Rauch, S. & Fackler, O. T. HIV-1 Nef employs two distinct mechanisms to modulate Lck subcellular localization and TCR induced actin remodeling. PLoS ONE 2, e1212 (2007).","journal-title":"PLoS ONE"},{"key":"8657_CR31","doi-asserted-by":"publisher","first-page":"5310","DOI":"10.1128\/JVI.74.11.5310-5319.2000","volume":"74","author":"LX Liu","year":"2000","unstructured":"Liu, L. X. et al. Mutation of a conserved residue (D123) required for oligomerization of human immunodeficiency virus type 1 Nef protein abolishes interaction with human thioesterase and results in impairment of Nef biological functions. J. Virol. 74, 5310\u20135319 (2000).","journal-title":"J. Virol."},{"key":"8657_CR32","doi-asserted-by":"publisher","first-page":"11081","DOI":"10.1128\/JVI.74.23.11081-11087.2000","volume":"74","author":"VK Arora","year":"2000","unstructured":"Arora, V. K. et al. Lentivirus Nef specifically activates Pak2. J. Virol. 74, 11081\u201311087 (2000).","journal-title":"J. Virol."},{"key":"8657_CR33","doi-asserted-by":"publisher","first-page":"40025","DOI":"10.1074\/jbc.M509075200","volume":"280","author":"JH Jung","year":"2005","unstructured":"Jung, J. H. & Traugh, J. A. Regulation of the interaction of Pak2 with Cdc42 via autophosphorylation of serine 141. J. Biol. Chem. 280, 40025\u201340031 (2005).","journal-title":"J. Biol. Chem."},{"key":"8657_CR34","doi-asserted-by":"publisher","first-page":"17347","DOI":"10.1074\/jbc.M009316200","volume":"276","author":"C Chong","year":"2001","unstructured":"Chong, C., Tan, L., Lim, L. & Manser, E. The mechanism of PAK activation. Autophosphorylation events in both regulatory and kinase domains control activity. J. Biol. Chem. 276, 17347\u201317353 (2001).","journal-title":"J. Biol. Chem."},{"key":"8657_CR35","doi-asserted-by":"crossref","unstructured":"Phee, H. et al. Pak2 is required for actin cytoskeleton remodeling, TCR signaling, and normal thymocyte development and maturation. eLife 3, e02270 (2014).","DOI":"10.7554\/eLife.02270"},{"key":"8657_CR36","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1083\/jcb.201807152","volume":"218","author":"HK Campbell","year":"2019","unstructured":"Campbell, H. K., Salvi, A. M., O\u2019Brien, T., Superfine, R. & DeMali, K. A. PAK2 links cell survival to mechanotransduction and metabolism. J. Cell Biol. 218, 1958\u20131971 (2019).","journal-title":"J. Cell Biol."},{"key":"8657_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.str.2016.11.001","volume":"25","author":"SJ Eron","year":"2017","unstructured":"Eron, S. J., Raghupathi, K. & Hardy, J. A. Dual site phosphorylation of Caspase-7 by PAK2 blocks apoptotic activity by two distinct mechanisms. Structure 25, 27\u201339 (2017).","journal-title":"Structure"},{"key":"8657_CR38","first-page":"1","volume":"9","author":"H Liu","year":"2021","unstructured":"Liu, H., Liu, K. & Dong, Z. The role of p21-activated kinases in cancer and beyond: where are we heading? Front. Cell Dev. Biol. 9, 1\u201312 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"8657_CR39","doi-asserted-by":"publisher","first-page":"118645","DOI":"10.1016\/j.bbamcr.2020.118645","volume":"1867","author":"J Huang","year":"2020","unstructured":"Huang, J. et al. PAK2 activated by Cdc42 and caspase 3 mediates different cellular responses to oxidative stress-induced apoptosis. Biochim. Biophys. Acta Mol. Cell Res. 1867, 118645 (2020).","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"8657_CR40","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s40425-018-0385-z","volume":"6","author":"BO Tschumi","year":"2018","unstructured":"Tschumi, B. O. et al. CART cells are prone to Fas- and DR5-mediated cell death. J. Immunother. Cancer 6, 71 (2018).","journal-title":"J. Immunother. Cancer"},{"key":"8657_CR41","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/mt.2016.63","volume":"24","author":"T Gargett","year":"2016","unstructured":"Gargett, T. et al. GD2-specific CAR T cells undergo potent activation and deletion following antigen encounter but can be protected from activation-induced cell death by PD-1 blockade. Mol. Ther. 24, 1135\u20131149 (2016).","journal-title":"Mol. Ther."},{"key":"8657_CR42","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.critrevonc.2008.01.002","volume":"66","author":"D Brenner","year":"2008","unstructured":"Brenner, D., Krammer, P. H. & Arnold, R. Concepts of activated T cell death. Crit. Rev. Oncol. Hematol. 66, 52\u201364 (2008).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"8657_CR43","doi-asserted-by":"crossref","unstructured":"Abraham, L. & Fackler, O. T. HIV-1 Nef: a multifaceted modulator of T cell receptor signaling. Cell Commun. Signal. 10, 39 (2012).","DOI":"10.1186\/1478-811X-10-39"},{"key":"8657_CR44","doi-asserted-by":"publisher","first-page":"6333","DOI":"10.1074\/jbc.271.11.6333","volume":"271","author":"Y Collette","year":"1996","unstructured":"Collette, Y. et al. Physical and functional interaction of Nef with Lck: HIV-1 Nef-induced T-cell signaling defects. J. Biol. Chem. 271, 6333\u20136341 (1996).","journal-title":"J. Biol. Chem."},{"key":"8657_CR45","first-page":"1","volume":"6753","author":"AI Salter","year":"2018","unstructured":"Salter, A. I. et al. Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function. Sci. Signal. 6753, 1\u201318 (2018).","journal-title":"Sci. Signal."},{"key":"8657_CR46","doi-asserted-by":"crossref","unstructured":"Majzner, R. G. et al. Tuning the antigen density requirement for CAR T-cell activity. Cancer Discov. 10, 702\u2013723 (2020).","DOI":"10.1158\/2159-8290.CD-19-0945"},{"key":"8657_CR47","doi-asserted-by":"publisher","first-page":"eaav5581","DOI":"10.1126\/sciimmunol.aav5581","volume":"4","author":"ME Snyder","year":"2019","unstructured":"Snyder, M. E. et al. Generation and persistence of human tissue-resident memory T cells in lung transplantation. Sci. Immunol. 4, eaav5581 (2019).","journal-title":"Sci. Immunol."},{"key":"8657_CR48","doi-asserted-by":"publisher","first-page":"eaah3732","DOI":"10.1126\/sciimmunol.aah3732","volume":"1","author":"J Zuber","year":"2016","unstructured":"Zuber, J. et al. Bidirectional intragraft alloreactivity drives the repopulation of human intestinal allografts and correlates with clinical outcome. Sci. Immunol. 1, eaah3732 (2016).","journal-title":"Sci. Immunol."},{"key":"8657_CR49","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/nm1101-1217","volume":"7","author":"D Wolf","year":"2001","unstructured":"Wolf, D. et al. HIV-1 Nef associated PAK and PI3-kinases stimulate Akt-independent bad-phosphorylation to induce anti-apoptotic signals. Nat. Med. 7, 1217\u20131224 (2001).","journal-title":"Nat. Med."},{"key":"8657_CR50","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1182\/blood-2013-03-478255","volume":"122","author":"H Torikai","year":"2013","unstructured":"Torikai, H. et al. Toward eliminating HLA class I expression to generate universal cells from allogeneic donors. Blood 122, 1341\u20131349 (2013).","journal-title":"Blood"},{"key":"8657_CR51","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41551-021-00730-z","volume":"5","author":"B Wang","year":"2021","unstructured":"Wang, B. et al. Generation of hypoimmunogenic T cells from genetically engineered allogeneic human induced pluripotent stem cells. Nat. Biomed. Eng. 5, 429\u2013440 (2021).","journal-title":"Nat. Biomed. Eng."},{"key":"8657_CR52","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41591-022-02182-7","volume":"29","author":"S Mailankody","year":"2023","unstructured":"Mailankody, S. et al. Allogeneic BCMA-targeting CAR T cells in relapsed\/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results. Nat. Med. 29, 422\u2013429 (2023).","journal-title":"Nat. Med."},{"key":"8657_CR53","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1182\/blood-2023-189196","volume":"142","author":"FL Locke","year":"2023","unstructured":"Locke, F. L. et al. ALLO-647 for lymphodepletion in the allogeneic CAR T setting: safety experience with ALLO-501\/501A in patients (Pts) with relapsed\/refractory (r\/r) large B-cell and follicular lymphomas. Blood 142, 2095\u20132095 (2023).","journal-title":"Blood"},{"key":"8657_CR54","doi-asserted-by":"crossref","unstructured":"Galli, E. et al. Hematopoiesis and immune reconstitution after CD19 directed chimeric antigen receptor T-cells (CAR-T): a comprehensive review on incidence, risk factors and current management. Eur. J. Haematol. 112, 184\u2013196 (2024).","DOI":"10.1111\/ejh.14052"},{"key":"8657_CR55","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/nbt0102-70","volume":"20","author":"J Maher","year":"2002","unstructured":"Maher, J., Brentjens, R. J., Gunset, G., Rivi\u00e8re, I. & Sadelain, M. Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCR\u03b6 \/CD28 receptor. Nat. Biotechnol. 20, 70\u201375 (2002).","journal-title":"Nat. Biotechnol."},{"key":"8657_CR56","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nm827","volume":"9","author":"R Brentjens","year":"2003","unstructured":"Brentjens, R. et al. Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15. Nat. Med. 9, 279 (2003).","journal-title":"Nat. Med."},{"key":"8657_CR57","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41591-021-01621-1","volume":"28","author":"J Mansilla-Soto","year":"2022","unstructured":"Mansilla-Soto, J. et al. HLA-independent T cell receptors for targeting tumors with low antigen density. Nat. Med. 28, 345\u2013352 (2022).","journal-title":"Nat. Med."},{"key":"8657_CR58","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.2307\/2532836","volume":"52","author":"G Heller","year":"1996","unstructured":"Heller, G. & Venkatraman, E. S. Resampling procedures to compare two survival distributions in the presence of right-censored data. Biometrics 52, 1204 (1996).","journal-title":"Biometrics"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-08657-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-08657-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-08657-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T13:02:25Z","timestamp":1744808545000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-08657-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,30]]},"references-count":58,"journal-issue":{"issue":"8059","published-print":{"date-parts":[[2025,4,17]]}},"alternative-id":["8657"],"URL":"https:\/\/doi.org\/10.1038\/s41586-025-08657-0","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,30]]},"assertion":[{"value":"26 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.P. and M.S. are co-inventors on a patent application filed on the subject matter of this study. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}